Brian A McCARTHY
Overview
Explore the profile of Brian A McCARTHY including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCARTHY B, Chong S, Parker G, Meramo M, Zhang M, Czarneski J, et al.
Cancer Genomics Proteomics
. 2019 Aug;
1(5-6):407-418.
PMID: 31394632
Background: The B-1 malignancy, CLL has been associated with a failure to undergo apoptosis and increased endogenous IL-10 production. This study was undertaken to identify IL-10 effects in the NZB...
2.
McCARTHY B, Yancopoulos S, Tipping M, Yan X, Wang X, Bennett F, et al.
Immunol Res
. 2015 Aug;
63(1-3):90-100.
PMID: 26318878
Chronic lymphocytic leukemia (CLL) is a clonal disease of B lymphocytes manifesting as an absolute lymphocytosis in the blood. However, not all lymphocytoses are leukemic. In addition, first-degree relatives of...
3.
Zha Y, Ding E, Yang L, Mao L, Wang X, McCARTHY B, et al.
PLoS One
. 2012 Aug;
7(8):e40728.
PMID: 22879880
Retinoic acid (RA) can induce growth arrest and neuronal differentiation of neuroblastoma cells and has been used in clinic for treatment of neuroblastoma. It has been reported that RA induces...
4.
McCARTHY B, Yang L, Ding J, Ren M, King W, Elsalanty M, et al.
BMC Cancer
. 2012 May;
12:203.
PMID: 22642622
Background: Abnormal NF-κB2 activation has been implicated in the pathogenesis of multiple myeloma, a cancer of plasma cells. However, a causal role for aberrant NF-κB2 signaling in the development of...
5.
HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma
Mao L, Ding J, Zha Y, Yang L, McCARTHY B, King W, et al.
Cancer Res
. 2011 Apr;
71(12):4314-24.
PMID: 21507931
Differentiation status in neuroblastoma strongly affects clinical outcomes and inducing differentiation is a treatment strategy in this disease. However, the molecular mechanisms that control neuroblastoma differentiation are not well understood....
6.
McCARTHY B, Reddi A, Coakley K, Nguyen S, Nayal R, Javdan M, et al.
Curr Stem Cell Res Ther
. 2009 Dec;
5(1):13-6.
PMID: 19951257
Recent studies from our laboratory have shown that intravenous administration of human umbilical cord blood (HUCB) mononuclear cells to mice improved blood glucose levels, survival, atherosclerosis and prostate cancer. In...
7.
McCARTHY B, Boyle E, Wang X, Guzowski D, Paul S, Catera R, et al.
Mol Med
. 2008 Jul;
14(9-10):618-27.
PMID: 18633450
Since its discovery in follicular lymphoma cells at the breakpoint t(14;18), Bcl-2 has been studied extensively in many basic and clinical science settings. Bcl-2 can locate as an integral mitochondrial...
8.
Raveche E, Schutzer S, Fernandes H, Bateman H, McCARTHY B, Nickell S, et al.
J Clin Microbiol
. 2005 Feb;
43(2):850-6.
PMID: 15695691
We investigated the possibility that manifestations of Lyme disease in certain hosts, such as arthritis and carditis, may be autoimmunity mediated due to molecular mimicry between the bacterium Borrelia burgdorferi...
9.
McCARTHY B, Mansour A, Lin Y, Kotenko S, Raveche E
Cancer Immun
. 2004 Jul;
4:6.
PMID: 15270555
RNA interference, or RNAi, is designed to work by Watson-Crick base pairing and to result in a posttranscriptional block in protein synthesis. Antiapoptotic proteins are a major focus of cancer...